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Objectives: The aim of this study was to determine the relation between functional measures of peripheral arterial disease
(PAD) severity with both disease-specific and generic self-reported health-related quality-of-life (HR-QOL) measures, as
well as the relation between the two types of HR-QOL measures.
Methods: This was a cross-sectional observation of participants from the community and primary care or vascular surgery
clinics in an academic Veterans Administration medical center. Eighty patients with symptomatic Fontaine stage II PAD
provided physiologic measures and self-response questionnaires. Objective measures included the ankle-brachial index
(ABI), time to maximum claudication pain on a graded exercise test, and a 6-minute floor-walking distance. Self-reports
included the Walking Impairment Questionnaire (WIQ), a disease-specific HR-QOLmeasure and the Medical Outcomes
Study (MOS) Short-Form 36 (SF-36), a generic HR-QOL measure.
Results: Patients (mean age 70 8 [ SD] and 85%men) exhibitedmoderate-to-severe PAD by objective measures of ABI
(0.65  0.19) and time in minutes to maximal claudication on a graded exercise test (7:54  4:58). Significant
correlations were found between these measures and the WIQ distance, MOS-Physical Function, and MOS-Role
Limitations due to physical dysfunction. The SF-36 and the WIQ subscales were significantly correlated.
Conclusion: In older PAD patients with intermittent claudication, objective measures of disease severity are correlated
with a self-reported, disease-specific and generic HR-QOL. (J Vasc Surg 2005;41:625-30.)Seven percent of older Americans have symptomatic
peripheral arterial occlusive disease (PAD).1 Health-related
quality of life (HR-QOL) is reduced in older patients with
PAD.2 Therapeutic interventions such as exercise rehabili-
tation and cilostazol that improve ambulatory functionmay
improve QOL. It is important for the clinician to under-
stand the relationship between HR-QOL and PAD. A
number of studies have examined this relationship. Al-
though HR-QOL is thought to be important measure of
disability, HR-QOL in patients with PAD is only partially
determined by the severity of functional impairment.3
Several questionnaires have been used to measure HR-
QOL in patients with PAD. The questionnaires include the
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Quality of Life Instrument,6-8 the Medical Outcomes
Study (MOS) Short Form 36 (SF-36) and its variant, the
Rand SF-36;9-11 and the Nottingham Health Profile.12 We
are not aware of any prospective study that has tried to
determine which instrument is best able to assess HR-QOL
in patients with PAD. Despite this, recommendations have
been made to use both disease-specific and generic health-
related QOL questionnaires in clinical studies to describe
the overall impact of claudication on physical function and
health status.13
The aim of this study was to determine the relationship
between functional measures of PAD severity with both
disease-specific and generic self-reported HR-QOL mea-
sures and to determine the relationship between the two
types of HR-QOL measures.
METHODS
Patient selection. Between July 1994 and June 1998,
community-dwelling patients with Fontaine stage II symp-
tomatic PAD were recruited and enrolled in clinical trials
designed to study the effects of exercise rehabilitation on
function in older patients with symptomatic PAD.14,15
Participants were from the Baltimore-Washington, DC,
metropolitan area and were recruited from the vascular
clinic at the Baltimore location of the Maryland Veterans
Affairs Health Care System, from University of Maryland
Hospital vascular surgery clinics, through newspaper and
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ters. The institutional review board of the University of
Maryland, Baltimore approved all procedures in this study.
All patients provided informed consent before participa-
tion.
The subjects received a comprehensive medical evalua-
tion to determine eligibility for the exercise training stud-
ies.14 It was designed to identify patients with Fontaine
stage II PAD who could safely exercise train at 70% to 80%
of their maximal workload as determined by the exercise
treadmill test. As part of the initial visit, a 6-minute walk
was performed, the Rose Claudication Questionnaire was
administered to the subjects,16 and their ankle-brachial
blood pressure index (ABI) was measured. At the second
visit, approximately 1 week later, medically eligible patients
received a symptom-limited exercise treadmill test and
completed HR-QOL surveys.
Subject inclusion criteria consisted of patients having
stage II PAD as defined by Fontaine, intermittent claudi-
cation reported on the Rose Questionnaire,16 lower-ex-
tremity pain during a screening treadmill test, and an ABI at
rest of 0.97 or a drop of the ABI to 0.85 during
exercise.
Subjects were excluded if they had
● Fontaine stage I PAD (asymptomatic disease),
● Fontaine stage III PAD (leg pain at rest),
● Fontaine stage IV PAD (PAD associated with tissue
loss),
● inability to exercise due to conditions other than clau-
dication, such as severe symptomatic coronary artery
disease, dyspnea, poorly controlled blood pressure, or
severe arthritis, or
● active cancer, renal disease, or liver disease.
We report data from 80 patients who completed all the
HR-QOL questionnaires and exercise testing.
Outcome measures. Ankle-brachial systolic pressure
index. Patients rested supine for 10 minutes, after which
ankle systolic and brachial systolic blood pressures were
recorded with a nondirectional Doppler flow detector
(model 810-A) (Parks Medical Electronics, Inc, Aloha,
Ore), a pencil probe (9.3 MHz), and a 10-cm width
(standard size) ankle blood pressure cuff. Measurements
were taken from the posterior tibial and dorsalis pedis
arteries in both legs. The higher of the two pressures in the
more severely diseased leg was recorded as the resting ankle
systolic pressure. Brachial blood pressure was measured
with a Critikon Dinamap Vital Signs Monitor (Model
1846-SX), with use of either a standard adult-size blood
pressure cuff or a large adult-size cuff.17 The ABI was
obtained by dividing the ankle systolic pressure by the
brachial systolic pressure of the arm with the higher systolic
blood pressure. The test-retest reliability and the coefficient
of variation are 0.97 and 12.8% for ankle systolic pressure
and 0.96 and 12.5% for the ABI with this methodology.18
Graded maximal treadmill test.19 Patients performed a
progressively graded treadmill test modified by Gardner et
al18 (2 mph speed starting at 0% grade and increasing 2%grade every 2 minutes) that ended when maximal claudica-
tion pain was reached. The primary outcome determined
by the treadmill test was the time to maximal claudication.
The test-retest reliability and the coefficient of variation for
the graded treadmill test time to maximal pain are 0.93 and
12.5%, respectively.18
Six-minute floor walk. This test measures the distance
(in feet) walked in 6 minutes at a regular pace on a flat
surface. If pain developed, patients were allowed to stop
and rest and then continue walking when the pain abated.
The test-retest reliability and coefficient of variation for the
6-minute walk total distance are 0.94 and 10.4%, respec-
tively.20
Health status and HR-QOL. Health status and HR-
QOL were assessed with the Walking Impairment Ques-
tionnaire (WIQ)21 and MOS SF-36 General Health Sur-
vey.22-24 The questionnaires were collected as secondary
outcome measures of our studies exploring the effects of
exercise rehabilitation on function in older patients with
symptomatic PAD. The WIQ is a reliable, validated, dis-
ease-specific questionnaire for patients with intermittent
claudication.21 It measures self-assessed ambulatory ability
in three subscales: stair climbing, walking speed, and dis-
tance walked. A score of 0 to 100 is used to measure each
domain, with a score of 0 representing inability to perform
the task and 100 representing no difficulty performing the
task.
The SF-36 is a reliable, valid, generic health status or
HR-QOL instrument.22 It has been used in many popula-
tions,23 including older veterans.25 It measures the eight
health domains of physical function, social function, role
limitations due to physical dysfunction, role limitations due
to emotional problems, mental health, bodily pain, general
health, and vitality. For each subscale, several item scores
are standardized into a scale from 0 to 100; better health
states result in higher scores. Table I lists the definitions of
the extreme scores in each subscale.26
Statistical analysis. Pearson correlation coefficients
were calculated between the objective measures of severity
of PAD (including the ABI, time to maximal claudication
time during an exercise stress test, and the 6-minute walk
distance) and perceived HR-QOL subscale scores of the
WIQ and MOS SF-36. A two-tailed P  .05 was taken as
significant. Results are reported as mean  SD.
RESULTS
Demographic information and functional assessments
of the 80 patients are summarized in Table II.
Both the disease-specific and the generic questionnaire
results suggest that the patients in our study identified
themselves as having a low QOL. As determined by WIQ,
the disease-specific questionnaire, our patients perceived
themselves as functionally impaired (Table III). The WIQ
measures were lower in our patients than those reported for
non-PAD patients (distance, 75  2; speed, 63  2; stairs,
66  2).27 The generic HR-QOL measure scores were also
decreased (Table III). The data from the SF-36 question-
naire indicates impairment in self-perceived physical per-
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due to physical health, and bodily pain subscales, support-
ing previous findings.14 Compared with national norms,26
our PAD patients scored lower in all subscales of the SF-36
except for the subscales of vitality, mental health, and social
functioning (Fig).
Many of the correlation coefficients between the objec-
tive measures of PAD severity and the subscales of theWIQ
were significant (Table IV). The ABI was significantly
correlated with the WIQ distance subscale, whereas time to
maximal claudication and 6-minute walk were significantly
correlated to all subscales of the WIQ. This suggests that
although the ABI is the most commonly used objective
measure of PAD, it may not give an accurate idea of the
impact of the disease in a person’s QOL.
All three objective measures of PAD severity (ABI, time
to maximal pain on the treadmill, and 6-minute walk) were
significantly correlated with the physical function and role
limitations due to physical dysfunction subscales of the
SF-36 (Table IV). Additionally, ABI was significantly cor-
related with bodily pain, and 6-minute walk was signifi-
cantly correlated with general health, vitality, and mental
Table I. Definitions of the extreme scores in the Medical 
Subscales Lowest possible scores
Physical functioning Very limited performance in all physical
including bathing and dressing
Role-physical Problems with work or activities of daily
result of physical health
Bodily pain Very severe and extremely limiting pain
General health Evaluates personal health as poor and be
likely to get worse
Vitality Feel tired and worn out all the time
Social functioning Extreme and frequent interference with
social activities due to physical and em
problems
Role-emotional Problems with work or activities of daily
result of emotional problems
Mental health Feelings of nervousness and depression a
time
Table II. Demographic and functional characteristics
of the 80 patients
Demographic information*
Age (years) 71  6
Male gender, n (%) 73 (91)
White, n (%) 47 (59)
Functional measures
Ankle-brachial index 0.67  0.17
Time to maximal pain (min:sec) 8:40  5:27
6-minute walk distance (feet) 1,239  277
*Data are mean  SDhealth. This suggests that although ABI is a good gage ofthe patient’s pain level, the 6-minute walk is a better
measure of the overall impact of PAD on QOL.
On the WIQ, the perceived ability to climb stairs, walk
at various speeds, and walk various distances were signifi-
cantly correlated with most of the eight SF-36 subscales
(Table V). The WIQ stair-climbing score was significantly
correlated with all eight subscales of the MOS SF-36 ques-
tionnaire, while the WIQ distance and speed scores were
significantly related to all of the SF-36 subscales, except for
role limitations due to emotional dysfunction. Thus, the
impact of PAD onHR-QOL can be captured by the disease
specific WIQ or by the generic scale SF-36.
DISCUSSION
HR-QOL is reduced in older patients with PAD.2 The
omes Study (MOS) Short Form 3626
nition of extreme scores
Highest possible score
ties Performance of all physical activities, including the
most vigorous without limitations due to health
concerns
g as a Indicate no problems with work or other activities of
daily living.
No pain or imitations due to pain
it is Evaluates personal health as excellent.
Full of pep and energy all the time
al
al
Performs normal social activities without interference
due to physical and emotional problems
g as a Indicate no problems with work or other activities of
daily living
the Feels peaceful, happy and calm all of the time
Table III. Health-related quality-of-life (HR-QOL)
measurements in 80 patients
Disease-specific HR-QOL
measurement*
Walking Impairment
Questionnaire score
Distance walked 37  32
Stair climbing 46  29
Speed walking 39  25
Generic quality of life measures
Medical Outcomes Study
Short Form-36 score
Physical functioning 56  19
Role-physical 63  40
Bodily pain 62  22
General health 61  21
Role-emotional 73  38
Vitality 63  19
Mental health 77  17
Social functioning 83  21
*Data are means  SDOutc
Defi
activi
livin
lieves
norm
otion
livin
ll ofresults of this study provide further information about the
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QOL among older patients with intermittent claudication.
We found that objective physiologic measures of PAD
severity are correlated with self-reported measures of func-
tional limitation.
The relation between physiologic measures of PAD
severity and measures of HR-QOL has previously been
assessed in patients with intermittent claudication by vari-
ous investigators. Feinglass et al28 examined the correlation
between abnormal ABI and HR-QOL measures, specifi-
cally, the SF-36Health Survey and theWIQ in 555 patients
(445 men and 110 women), none of whom had had
previous leg revascularization or symptoms of rest pain,
skin ulcers, or gangrene. Correlations with ABI were mod-
est between the physical function subscale of SF-36 (r 
0.12, P  .004) and WIQ distance score (r  0.18, P 
.001).25
In the present study, the correlations between the ABI
and physical function subscale of the SF-36 and the dis-
tance walked subscale of the WIQ were larger (r  0.42,
P  .001 and r  0.29, P  .01, respectively). Further-
more, we examined the inter-relationships among generic
and disease-specific measures of HR-QOL and objective
measures of ambulatory function determined from a
graded exercise test and a 6-minute walk test in patients
limited by intermittent claudication. These data extend our
previous observations that bodily pain and reductions in
physical function, as measured by the SF-36 subscales,
contributed strongly to the reduction in QOL in these
patients.11
Several groups have examined the correlation between
treadmill performance and HR-QOL measures in patients
with intermittent claudication. All studies found that max-
Comparison of Medical Outcome Study Short 36 (MOS SF-36)
scores in the general population (striped) and in the participants of
our study (solid).imal distance walked on a treadmill was significantly corre-lated with self-reported QOL,4,6,8,29,30 although in one
study the association was found only in the subgroup of
patients who were currently employed and only for the
physical function subscale of the McMaster Health Index
Questionnaire.4
In our study, we found statistically significant correla-
tions between time to maximal pain on the graded exercise
test, an objective measure of disease severity, and all thee
subscales of the WIQ and three of the eight SF-36 sub-
scales: physical function, role limitations due to physical
dysfunction, and mental health. Similar correlations were
found with the 6-minute floor-walking distances. It would
thus appear that these functional measures are more closely
related to QOL in PAD patients limited by intermittent
claudication than is ABI. Finally, the disease-specific mea-
sure of QOL in our study correlated with multiple domains
of the generic SF-36 in PAD patients, with the stronger
correlations found between the subscales of physical func-
tioning and the WIQ.
In a clinical setting, obtaining objective measures of
ambulatory function with a graded exercise test is labor
intensive and may be impractical in many settings. Con-
ducting a 6-minute walk test to objectively quantify ambu-
latory function is a practical alternative that is less labor
intensive, but it still requires trained personnel and neces-
sary space. In settings where ambulatory function needs to
be assessed in a brief period of time, particularly in the
primary care setting, clinicians could administer simple
questionnaires such as the WIQ to estimate functional
status. The WIQ and MOS SF-36 questionnaires provide
useful information about the impact of PAD in the patient’s
life without increasing the burden of patient care.
One of the strengths of this study was that we recruited
and characterized a PAD population with a well-described
stage of disease. One study limitation was that the study
patients represented a selected group who volunteered for
this research study and might not be representative of the
general population of patients with Fontaine stage II PAD.
A second limitation was that the QOL questionnaires
were administered at the second screening visit. The
intent of the parent study (exploring the effects of exer-
cise rehabilitation on function in older patients with
symptomatic PAD) was to enroll patients with Fontaine
stage II functionally limited by claudication into the
clinical trial. Potential research subjects were initially
interviewed over the phone and then brought in for
several medical screening visits.
Patients with the most severe PAD (Fontaine stage III
or IV)—patients with the most severe medical comorbidi-
ties that would interfere with their ability to exercise train—
were deemed ineligible from the results of their initial
screening medical visit. They were excluded before they
had the opportunity to perform the treadmill exercise test
and did not complete the HR-QOL questionnaires. Pa-
tients with mild disease and not functionally limited by
claudication (Fontaine stage I) were also excluded at the
first visit, and additional assessments were not performed.
In addition, a few patients seen at visit two did not com-
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have been different if we had included patients with more
severe or less severe disease.
Third, the MOS was administered after the graded
exercise test; therefore, the response, especially for the
physical function subscale, could have been biased.
Our findings suggest that physiologic measures of
PAD severity correlate with specific subscales (physical
functioning) of the generic (SF-36) measure and with
disease-specific measures (WIQ). This suggests that both
generic and disease specific questionnaires can provide
insight into HR-QOL in patients with PAD.
Appreciation is extended to Lynda Cowell, MS and
Tresa Almy-Albert, MS, for testing and rehabilitating the
patients and Dr Andrew P Goldberg for his scientific input
Table V. Correlation coefficients between the disease-
specific Walking Impairment Questionnaire and the
generic Medical Outcomes Study Short Form-36 (MOS
SF-36) health-related quality of life scores in 80 patients
MOS SF-36
Walking Impairment Questionnaire
Distance Stair Speed
Physical functioning 0.48‡ 0.56‡ 0.38†
Role-physical 0.28† 0.39† 0.32†
Bodily pain 0.29† 0.38† 0.21*
General health 0.30† 0.54‡ 0.39†
Role-emotional 0.18 0.25† 0.10
Vitality 0.25* 0.42† 0.36†
Mental health 0.21* 0.39† 0.36†
Social functioning 0.26* 0.29† 0.24*
*P  .05;
†P  .01;
‡P  .001
Table IV. Correlation coefficients between objective mea
quality-of-life (HR-QOL) measures in 80 patients
Disease specific HR-QOL measurement
Ankle-b
ind
Walking Impairment Questionnaire Score
Distance walked 0.2
Stair climbing 0.2
Speed walking 0.1
Generic quality of life measures
Medical Outcomes Study Short-Form 36
Physical functioning 0.4
Role-physical 0.2
Bodily pain 0.3
General health 0.1
Role-emotional 0.0
Vitality 0.1
Mental health 0.0
Social functioning 0.0
*P  .05;
†P  0.01;
‡P  .001into the design of the study.REFERENCES
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